Amit Verma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma (NCT01378871) | Amit Verma | 2010-09-01 |
Track Amit Verma automatically
Every clearance here is in the API, with alerts when new ones post.